Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1707 in Endometriosis Associated Pelvic Pain
NCT01767090Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of opigolix in endometriosis, sponsored by Astellas Pharma. Started Dec 2012; status: completed.
02
Drugs
opigolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01767090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767090.